β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939.
Saved in:
| Title: | β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939. |
|---|---|
| Authors: | Umar SM; Department of Medical Oncology (Lab), Dr BRA IRCH, AIIMS, Ansari Nagar, New Delhi, India., Kahol S; Department of Pathology, AIIMS, Ansari Nagar, New Delhi, India., Mathur SR; Department of Pathology, AIIMS, Ansari Nagar, New Delhi, India., Gogia A; Department of Medical Oncology, Dr BRA IRCH, AIIMS, Ansari Nagar, New Delhi, India., Deo SVS; Department of Surgical Oncology, Dr BRA IRCH, AIIMS, Ansari Nagar, New Delhi, India., Pandey S; Department of Biostatistics, AIIMS, Ansari Nagar, New Delhi, India., Prasad CP; Department of Medical Oncology (Lab), Dr BRA IRCH, AIIMS, Ansari Nagar, New Delhi, India. |
| Source: | Technology in cancer research & treatment [Technol Cancer Res Treat] 2026 Jan-Dec; Vol. 25, pp. 15330338261425407. Date of Electronic Publication: 2026 Feb 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Country of Publication: United States NLM ID: 101140941 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-0338 (Electronic) Linking ISSN: 15330338 NLM ISO Abbreviation: Technol Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
